Cobimetinib - Genentech/Exelixis
At a glance
- Drug Originator Exelixis
- Drug Licenced by Genentech
- Drug Class Antineoplastics; Azetidines; Fluorobenzenes; Iodobenzenes; Small molecules
- Mechanism of Action Mitogen-activated protein kinase kinase inhibitors
- USA Patent Applicants GENENTECH INC
- USA Patents 9
- NDAs 1
- International Patents 175
- Patent Applications 1
Table of Contents

Disclaimer